PPD, Inc. (PPD) 是一家上市公司 屬於 醫療保健 板塊，經營於 制药 - 专科与仿制药 產業. 公司總部位於 Wilmington, NC, 美国. 現任CEO為 David S. Simmons.
PPD 擁有 IPO日期為 2020-02-06, 30,000 名全職員工, 在 NASDAQ Global Select.
PPD, Inc. provides drug development services to the biopharmaceutical industry worldwide. The company operates through Clinical Development Services and Laboratory Services segments. It offers clinical development services, including product development and consulting, early development, Phases II-IV clinical trial management, accelerated enrollment, peri- and post-approval, and medical communications services. The company also provides laboratory services comprising bioanalytical, biomarker, vaccine science, good manufacturing practice, and central laboratory services. It serves pharmaceutical, biotechnology, medical device, and government organizations, as well as other industry participants. The company was founded in 1985 and is headquartered in Wilmington, North Carolina.
